ClearPoint Neuro, Inc. (CLPT)

Market Cap	319.11M
Revenue (ttm)	32.24M
Net Income (ttm)	-20.79M
Shares Out	28.27M
EPS (ttm)	-0.75
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	373,360
Open	11.26
Previous Close	11.26
Day's Range	11.02 - 11.39
52-Week Range	5.11 - 19.22
Beta	0.92
Analysts	Strong Buy
Price Target	27.67 (+145.08%)
Earnings Date	Aug 6, 2025

About CLPT

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; li...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 115
• Stock Exchange: NASDAQ
• Ticker Symbol: CLPT
• Website: https://www.clearpointneuro.com

Financial Performance

In 2024, ClearPoint Neuro's revenue was $31.39 million, an increase of 31.04% compared to the previous year's $23.96 million. Losses were -$18.91 million, -14.37% less than in 2023.

Analyst Summary

According to 3 analysts, the average rating for CLPT stock is "Strong Buy." The 12-month stock price target is $27.67, which is an increase of 145.08% from the latest price.

Price Target

$27.67

(145.08% upside)

Analyst Consensus: Strong Buy